Toxic effects of chemicals: difficulties in extrapolating data from animals to man.

This review attempts an analysis of the major components which make it extremely difficult to extrapolate toxicological data obtained with chemicals from animals to man. A first problem concerns the use of doses to express the unit of comparison across animal species; the dose is a parameter exogenous to the body and when a chemical enters the body concentrations should be utilized. There is in fact evidence that for several chemicals equal doses in different animal species do not mean equal concentrations in blood or tissues. Concentrations of chemicals should be measured for extrapolation purposes as close as possible to the site of the toxic effect. A second problem regards the fact that several chemical are transformed in the body into other chemical species--sometimes few and sometimes many--and some of these species (active metabolites) display biological activity in some cases higher than different from or antagonistic to those of the parent compounds. Some of these metabolites are highly reactive and therefore bind to body components, particularly macromolecules such as proteins and nucleic acids. There is evidence that metabolism is quantitatively and/or qualitatively different in various animal species. A third problem concerns the difference in various animal species in the biological substrates on which chemicals exert their toxic effects. Equal concentrations of chemicals and their metabolites do not mean equal toxic effects across animal species because endogenous metabolic processes, cell permeability, enzymes, and receptors are not necessarily the same in animals and man. To overcome these difficulties there is a need for closer integration of different disciplines in the toxicological evaluation of chemicals. A scientific rather than a routine approach in toxicology is emphasized.

[1]  S. Garattini,et al.  Benzodiazepines: Clinical Pharmacology and Therapeutic Use , 1980, Drugs.

[2]  B. Hill,et al.  A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry , 2004, Cancer Chemotherapy and Pharmacology.

[3]  S. Garattini,et al.  Influence of tumor on adriamycin concentration in blood cells , 2004, Cancer Chemotherapy and Pharmacology.

[4]  A. Jori,et al.  A genetic analysis of the hyperthermic response to d-amphetamine in two inbred strains of mice , 1978, Psychopharmacology.

[5]  Y. Olsson,et al.  Blood-brain barrier to albumin in embryonic new born and adult rats , 1968, Acta Neuropathologica.

[6]  G. Damia,et al.  Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding. , 1986, Oncology.

[7]  E. Dejana,et al.  Differential Salicylate–Aspirin Interaction on Vascular Prostacyclin and Platelet Thromboxane Synthesis in Patients Undergoing Saphenectomy , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  Michael Balls,et al.  Animals and Alternatives in Toxicity Testing , 1985 .

[9]  C. Cerletti,et al.  Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. , 1985, The Journal of laboratory and clinical medicine.

[10]  S. Garattini,et al.  1-Aryl-piperazine as active metabolites of drugs with an aryl-piperazine side-chain , 1985 .

[11]  M. Lampugnani,et al.  Effects of metabolized and unmetabolized arachidonate on rat platelet shape change. , 1984, The American journal of physiology.

[12]  R. Fanelli,et al.  Characterization of arachidonic acid metabolic profiles in animal tissues by high-resolution gas chromatography-mass spectrometry. , 1984, Biochimica et biophysica acta.

[13]  M. Bonati,et al.  Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. , 1984, The Journal of laboratory and clinical medicine.

[14]  M. Boyd,et al.  Reactive metabolites from the bioactivation of toxic methylfurans. , 1984, Science.

[15]  M. Broggini,et al.  Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors. , 1984, Cancer treatment reports.

[16]  M. Bonati,et al.  Kinetics and metabolism of theobromine in male rats. , 1984, Toxicology.

[17]  G. Remuzzi,et al.  The metabolism of arachidonic acid by platelets in nephrotic syndrome. , 1984, Kidney international.

[18]  S. Garattini,et al.  A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteers. , 1984, Thrombosis research.

[19]  L. T. Webster,et al.  4-Keto niridazole: a major niridazole metabolite with central nervous system toxicity different than niridazole. , 1984, The Journal of pharmacology and experimental therapeutics.

[20]  A. Mantovani,et al.  Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. , 1984, Journal of immunology.

[21]  S. Garattini,et al.  Pharmacokinetic studies of anticancer drugs in tumor-bearing animals. , 1984, Cancer treatment reports.

[22]  F. Landoni,et al.  In vitro cytotoxicity of VP-16213 on human ovarian cancer. , 1984 .

[23]  John F. Young,et al.  Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. , 1984, Drug metabolism reviews.

[24]  S. Garattini,et al.  Long-acting and short-acting benzodiazepines in the elderly: kinetic differences and clinical relevance. , 1984, Current medical research and opinion.

[25]  G. Remuzzi,et al.  Steroids and Adriamycin nephrosis. , 1984, Applied pathology.

[26]  A. Bizzi,et al.  Adriamycin causes hyperlipemia as a consequence of nephrotoxicity. , 1983, Toxicology letters.

[27]  A. Yacobi,et al.  Age-related pharmacokinetics of N-acetylprocainamide in rats. , 1983, Journal of pharmaceutical sciences.

[28]  E. Garattini,et al.  Intact rat liver nuclei catalyze adriamycin irreversible interactions with DNA and nuclear proteins. , 1983, Toxicology letters.

[29]  P. Alster,et al.  Biosynthesis of prostaglandins in microsomes of human skeletal muscle and kidney. , 1983, Prostaglandins, leukotrienes, and medicine.

[30]  M. Broggini,et al.  Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice. , 1983, Cancer treatment reports.

[31]  G. Williams,et al.  GENOTOXIC AND EPIGENETIC CARCINOGENS: THEIR IDENTIFICATION AND SIGNIFICANCE , 1983, Annals of the New York Academy of Sciences.

[32]  S. Garattini NOTES ON XENOBIOTIC METABOLISM , 1983, Annals of the New York Academy of Sciences.

[33]  M. Broggini,et al.  Subcellular distribution of adriamycin in the liver and tumor of 3LL-bearing mice. , 1983, European journal of cancer & clinical oncology.

[34]  S. Garattini,et al.  Metabolic and pharmacological studies with N-methyl-N'-methyl-2'-allyl-2-benzoyl-4-chloro-glycinanilide (F 1797). , 1983, Arzneimittel-Forschung.

[35]  P. Uotila Arachidonate metabolism is changed by dipyridamole in guinea pig isolated lungs. , 2009, Acta pharmacologica et toxicologica.

[36]  J. Blanchard Protein binding of caffeine in young and elderly males. , 1982, Journal of pharmaceutical sciences.

[37]  T. Eling,et al.  Metabolism of prostaglandin endoperoxide by microsomes from human lung parenchyma and comparison with metabolites produced by pig, bovine, rat, mouse and guinea-pig. , 1982, Prostaglandins.

[38]  M. Lampugnani,et al.  Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets. , 1982, Biochemical pharmacology.

[39]  S. Garattini,et al.  Pseudodementia in the elderly: Differential diagnosis and treatment. , 1982 .

[40]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[41]  G. Yee,et al.  The anticancer agent adriamycin can be actively cytotoxic without entering cells. , 1982, Science.

[42]  S. Garattini,et al.  Species differences in the kinetics and metabolism of fenfluramine isomers. , 1982, Archives internationales de pharmacodynamie et de therapie.

[43]  M. Bonati,et al.  Clinical Pharmacokinetics of Cerebrospinal Fluid , 1982, Clinical pharmacokinetics.

[44]  S. Garattini,et al.  D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. , 1982, Pharmacological research communications.

[45]  P. Ghezzi,et al.  IFN-beta-induced reduction of superoxide anion generation by macrophages. , 1982, Immunology.

[46]  S. Garattini,et al.  Benzodiazepines: Relationship between pharmacological activity in the rat and in vivo receptor binding , 1982, Pharmacology Biochemistry and Behavior.

[47]  M. D’Incalci,et al.  In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma. , 1982, European journal of cancer & clinical oncology.

[48]  R. Weiss,et al.  The renal toxicity of cancer chemotherapeutic agents. , 1982, Cancer treatment reviews.

[49]  A. Mantovani,et al.  IMMUNOSUPPRESSANT ACTIVITY OF TCDD IN MICE , 1982 .

[50]  A. Mantovani,et al.  Tumoricidal and immunoregulatory activity of macrophages from human ovarian carcinomas. , 1982, Advances in Experimental Medicine and Biology.

[51]  M. Gross,et al.  Persistence of TCDD in monkey adipose tissue. , 1982, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[52]  T. Croci,et al.  Persistent tissue levels of TCDD in the mouse and their reduction as related to prevention of toxicity. , 1982, Drug metabolism reviews.

[53]  S. Garattini,et al.  Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain. , 1982, Journal of chromatography.

[54]  J. Ouslander Drug therapy in the elderly. , 1981, Annals of internal medicine.

[55]  S. Garattini,et al.  Plasma kinetics and urinary elimination of saccharin in man. , 1981, Toxicology letters.

[56]  C. McClain,et al.  Depression of aminopyrine metabolism by influenza vaccination. , 1981, The New England journal of medicine.

[57]  M. Broggini,et al.  Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit. , 1981, European journal of cancer & clinical oncology.

[58]  S. Garattini,et al.  Antileptazol activity and kinetics of clobazam and N-desmethyl-clobazam in the guinea-pig. , 1981, Archives internationales de pharmacodynamie et de therapie.

[59]  E. Dejana,et al.  Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. , 1981, The Journal of clinical investigation.

[60]  B. Sinha,et al.  Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding. , 1981, Biochemical pharmacology.

[61]  S. Garattini,et al.  Relationship between camazepam, N‐methyl‐oxazepam and oxazepam brain concentrations and antileptazol effect in the rat , 1981, The Journal of pharmacy and pharmacology.

[62]  S. Garattini,et al.  (—)‐m‐Chlorophenyl‐piperazine, a central 5‐hydroxytryptamine agonist, is a metabolite of trazodone , 1981, The Journal of pharmacy and pharmacology.

[63]  E. Dejana,et al.  Salicylate-Aspirin Interaction and Thrombosis Prevention Trials , 1981, Thrombosis and Haemostasis.

[64]  R. Fanelli,et al.  Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine, by gas-liquid chromatography. , 1981, Journal of chromatography.

[65]  E. Dejana,et al.  Effects of an Epoxymethano Stable Analogue of Prostaglandin Endoperoxides (U-46619) on Human Platelets , 1981, Thrombosis and Haemostasis.

[66]  P. Allavena,et al.  Intraperitoneal administration of corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor‐associated macrophages and NK cells , 1981, International journal of cancer.

[67]  A. Mantovani,et al.  Effects of saccharin on primary humoral antibody production in rats. , 1981, Toxicology letters.

[68]  Y. Schneider,et al.  Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles. , 1981, European journal of cancer.

[69]  P. Ghezzi,et al.  Evidence for covalent binding of adriamycin to rat liver microsomal proteins. , 1981, Biochemical pharmacology.

[70]  R. Samanin Central mechanisms of anorectic drugs , 1981 .

[71]  S. Garattini Central mechanisms of fenfluramine and related anorectic drugs. , 1981, Japanese journal of pharmacology.

[72]  P. Puccetti,et al.  Depression of hepatic biotransformations by chemical immunoadjuvants. , 1981, Journal of immunopharmacology.

[73]  S. Garattini,et al.  Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice. , 1981, Cancer treatment reports.

[74]  P. Ghezzi,et al.  Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice. , 1980, Toxicology letters.

[75]  E. Dejana,et al.  Impaired Thromboxane Production by Newly Formed Platelets after Aspirin Administration to Thrombocytopenic Rats , 1980, British journal of haematology.

[76]  M. Bonati,et al.  Caffeine disposition and effects in young and one‐year‐old rats , 1980, The Journal of pharmacy and pharmacology.

[77]  S. Garattini,et al.  Brain concentrations of clobazam and N‐desmethylclobazam and antileptazol activity , 1980, The Journal of pharmacy and pharmacology.

[78]  M. Salmona,et al.  Possible relevance of N-trifluoroacetyladriamycin (AD 41) in the antitumoral activity of N-trifluoroacetyladriamycin-14-valerate (AD 32) in tumor-bearing mice. I. Pharmacokinetic evidence. , 1980, Cancer treatment reports.

[79]  M. Broggini,et al.  Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats. , 1980, Cancer treatment reports.

[80]  B. Sinha,et al.  Binding of [14C]-adriamycin to cellular macromolecules in vivo. , 1980, Biochemical pharmacology.

[81]  A. Mantovani,et al.  In vitro effects of saccharin on cell-mediated host defence mechanisms. , 1980, Toxicology letters.

[82]  J. M. Simpson,et al.  Toxicogenetics of niridazole in inbred mice. , 1980, The Journal of pharmacology and experimental therapeutics.

[83]  T. Tung,et al.  Serum free amino acid levels after oral glutamate intake in infant and adult humans. , 1980 .

[84]  S. Garattini,et al.  Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity. , 1980, Oncology.

[85]  G. Minno,et al.  Prostaglandins as Inhibitors of Human Platelet Aggregation , 1979, British journal of haematology.

[86]  D. Nebert,et al.  Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. , 1979, The Journal of biological chemistry.

[87]  W. F. Greenlee,et al.  Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Role of the hepatic cytosol receptor protein. , 1979, The Journal of biological chemistry.

[88]  S. Garattini,et al.  Quantitative thin-layer chromatographic measurement of n-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues. , 1979, Journal of chromatography.

[89]  L. Greenberg,et al.  Age-related alterations in the development of adrenergic denervation supersensitivity. , 1979, Federation proceedings.

[90]  C. Cerletti,et al.  Human platelet monoamine oxidase activity in glaucoma. , 1979, Investigative ophthalmology & visual science.

[91]  F. Cavagna,et al.  Kinetics and metabolism of clobazam in animals and man. , 1979, British journal of clinical pharmacology.

[92]  B. Ghetti,et al.  Effect of aging on neurotransmitter receptor binding in rat and human brain. , 1979, Life sciences.

[93]  A. Mantovani,et al.  Cytolytic and cytostatic activity on tumor cells of circulating human monocytes , 1979, International journal of cancer.

[94]  S. Snyder,et al.  Distinct α-noradrenergic receptors differentiated by binding and physiological relationships , 1979 .

[95]  A. Y. Lu Multiplicity of liver drug metabolizing enzymes. , 1979, Drug metabolism reviews.

[96]  M. Bonati,et al.  Dose-dependent kinetics of caffeine in rats , 1978 .

[97]  N. Bachur,et al.  A general mechanism for microsomal activation of quinone anticancer agents to free radicals. , 1978, Cancer research.

[98]  T. D. Bell,et al.  ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESS , 1978, The Lancet.

[99]  P. Tulkens,et al.  Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. , 1978, European journal of cancer.

[100]  Y. Takasaki Studies on brain lesions after administration of monosodium L-glutamate to mice. II. Absence of brain damage following administration of monosodium L-glutamate in the diet. , 1978, Toxicology.

[101]  S. Garattini SOME EXAMPLES OF RESISTANCE TO PSYCHOTROPIC DRUGS IN ANIMALS AND MAN , 1978 .

[102]  R. Fanelli,et al.  Arene oxides in styrene metabolism, a new perspective in styrene toxicity? , 1978, Scandinavian journal of work, environment & health.

[103]  F. Sun,et al.  Metabolism of prostaglandin endoperoxide in animal tissues. , 1977, Prostaglandins.

[104]  M. Boyd Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.

[105]  K. C. Majumdar,et al.  Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. , 1977, Biochemical and biophysical research communications.

[106]  G. Rangaraj,et al.  Distribution of prostaglandin biosynthetic pathways in several rat tissues. Formation of 6-ketoprostaglandin F1alpha. , 1977, Biochimica et biophysica acta.

[107]  N. Saunders,et al.  Ontogeny of the blood-brain barrier. , 1977, Experimental eye research.

[108]  B. Koe Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. , 1976, The Journal of pharmacology and experimental therapeutics.

[109]  E. Erba,et al.  Cytotoxic Activity of in Vitro Activated Cyclophosphamide on Tumors in Primary Culture 1 , 1976, Tumori.

[110]  M. Meltzer,et al.  Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. , 1976, Cellular immunology.

[111]  S. Caccia,et al.  Further studies on brain concentrations of amphetamine and its metabolites in strains of mice showing different sensitivity to pharmacological effects of amphetamine , 1975, The Journal of pharmacy and pharmacology.

[112]  N. Saunders,et al.  Complex tight junctions of epithelial and of endothelial cells in early foetal brain , 1975, Journal of neurocytology.

[113]  E. Glover,et al.  Genetic Expression of Aryl Hydrocarbon Hydroxylase by 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Evidence for a Receptor Mutation in Genetically Non-responsive Mice , 1975 .

[114]  S. Garattini,et al.  Biotransformation of Drugs to Pharmacologically Active Metabolites , 1975 .

[115]  F. Luft,et al.  Renal parenchymal accumulation of aminoglycoside antibiotics in rats. , 1974, The Journal of infectious diseases.

[116]  C. Cerletti,et al.  3H-reserpine persistently bound "in vivo" to rat brain subcellular components: limited removal by peanut oil extraction. , 1974, Life sciences.

[117]  S. Garattini,et al.  Catecholamine metabolism and amphetamine effects on sensitive and insensitive mice , 1974 .

[118]  T. A. Connors,et al.  Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. , 1974, Biochemical pharmacology.

[119]  J. Olney,et al.  Glutamate accumulation in infant mouse hypothalamus: influence of temperature. , 1973, Brain research.

[120]  J. Olney,et al.  ACCUMULATION OF GLUTAMIC ACID IN THE ARCUATE NUCLEUS OF THE HYPOTHALAMUS OF THE INFANT MOUSE FOLLOWING SUBCUTANEOUS ADMINISTRATION OF MONOSODIUM GLUTAMATE 1 , 1972, Journal of neurochemistry.

[121]  A. Coutinho,et al.  The metabolism of niridazole (AMBILHARR) in man. II. Investigations on patients suffering from clinically advanced forms of Schistosoma mansoni infection. , 1970, Annals of tropical medicine and parasitology.

[122]  A. Coutinho,et al.  TREATMENT OF HEPATOSPLENIC SCHISTOSOMIASIS MANSONI WITH NIRIDAZOLE: RELATIONSHIPS AMONG LIVER FUNCTION, EFFECTIVE DOSE, AND SIDE EFFECTS , 1969, Annals of the New York Academy of Sciences.

[123]  J. Olney Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate , 1969, Science.

[124]  J. Gillette,et al.  Microsomes and drug oxidations , 1968 .

[125]  R. Blasberg Specificity of cerebral amino acid transport: a kinetic analysis. , 1968, Progress in brain research.

[126]  A. Pletscher Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. , 1968, British journal of pharmacology and chemotherapy.

[127]  E. Dolfini,et al.  Studies with amphetamine in hyper- and hypothyroid rats. , 1967, European journal of pharmacology.

[128]  A. Lajtha,et al.  Heterogeneity of the mediated transport systems of amino acid uptake in brain. , 1966, Brain research.

[129]  J. Axelrod,et al.  The fate of caffeine in man and a method for its estimation in biological material. , 1953, The Journal of pharmacology and experimental therapeutics.